37014.1 IP-LS

Résumé

New PET Tracers established on a novel Cu-61 Platform

Textes supplémentaires

Abstract

Life-saving cancer therapy can be prescribed through precise diagnostic imaging with Positron Emission Tomography (PET). A restriction to its use is mainly due to the suboptimal qualities of the PET tracers. Swiss Nuclides intends to provide new Copper-61 PET tracers that can overcome this barrier.

Participants

Leila Jaafar

Wirtschaftspartner

leila.jaafar@swissnuclides.ch

Nuclidium AG CHE-412.395.606 Leila Jaafar Bäumleingasse 18 4051 Basel BS CH

Melpomeni Fani

Kontaktperson

Universität Basel Melpomeni Fani Petersgraben 4 4031 Basel BS CH

Détails du projet

Office de recherche: INNOSUISSE
Statut du projet: Abgeschlossen
Type de projet: Forschungsprojekt
Date de début: 2020-10-31
Date de fin: 2023-02-28
Coûts totaux approuvés: CHF 583868.04
Section: 60 Life Sciences
Domaine politique NABS: Industrielle Produktivität und Technologie

Disciplines de recherche

B007 Medicine (human and vertebrates) 100.0%